Key Stats

Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.99% 0.17% 163.11M 44496.73
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.44% 16.00% -11.07M Upgrade

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Leveraged Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Health
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Health Care Select Sector TR USD 300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 11.72 yrs
Tony Ng 7.42 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 83
-11.07M
-474.20M Category Low
4.729B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 17, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-17.46%
69.32%
2.81%
55.67%
4.93%
88.30%
-20.50%
-23.04%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
2.41%
31.59%
59.56%
-13.48%
47.99%
2.12%
41.97%
-19.47%
-8.19%
31.36%
39.28%
-22.64%
66.16%
-20.34%
67.89%
-32.10%
-14.40%
70.34%
-11.60%
-55.94%
17.14%
-91.59%
111.8%
130.7%
-24.99%
-8.75%
46.92%
3.36%
40.40%
19.23%
48.06%
-15.26%
-14.84%
As of March 17, 2023.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-20-23) 0.44%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 21.62
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of March 19, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of March 19, 2023

Asset Allocation

As of March 19, 2023.
Type % Net % Long % Short
Cash 30.77% Upgrade Upgrade
Stock 60.29% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 8.94% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Dreyfus Government Secs Cash Mgmt Admin 13.73% 1.00 0.00%
Goldman Sachs FS Treasury Intms Instl 11.92% 1.00 0.00%
GOLDMAN
8.94% -- --
UnitedHealth Group Inc 7.16% 476.96 1.59%
Johnson & Johnson 6.50% 153.89 0.99%
Goldman Fs Govt Inst
5.12% -- --
AbbVie Inc 4.45% 156.12 1.23%
Merck & Co Inc 4.31% 105.85 1.68%
Eli Lilly and Co 4.24% 333.60 1.34%
Pfizer Inc 3.67% 40.81 1.77%

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Leveraged Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Health
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Health Care Select Sector TR USD 300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 11.72 yrs
Tony Ng 7.42 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-20-23) 0.44%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 21.62
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of March 19, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of March 19, 2023

Fund Details

Key Dates
Inception Date 6/15/2011
Last Annual Report Date 10/31/2022
Last Prospectus Date 2/28/2023
Attributes
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0